BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report)’s share price traded down 3.8% during mid-day trading on Thursday . The company traded as low as $0.87 and last traded at $0.91. 62,883 shares traded hands during mid-day trading, an increase of 14% from the average session volume of 55,024 shares. The stock had previously closed at $0.95.
Analyst Ratings Changes
Separately, HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of BiomX in a research report on Wednesday, January 8th.
View Our Latest Research Report on PHGE
BiomX Price Performance
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Read More
- Five stocks we like better than BiomX
- Stock Average Calculator
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What Do S&P 500 Stocks Tell Investors About the Market?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Invest in Biotech Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
